Abstract
The diseases covered below all feature erythematous or papular lesions which often become covered with scale. The term papulosquamous is most often used in the USA but fails to correctly describe diseases such as pityriasis rosea which has erythematous macules and then scale, but never papules. Thus we prefer erythematosquamous, even though it is not widely used in English. Most of these diseases have an unclear etiology and their appearance in the same chapter should not be interpreted as evidence of any biologic relationship.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Bibliography
Erythemas Flushing
Wilkin JK (1993) The red face: flushing disorders. Clin Dermatol 11:211–223
Blushing
Drott C, Claes G, Olsson R (1998) Successful treatment of facial blushing by endoscopic transthoracic sympathicotomy. Br J Dermatol 138:639–643
Flushing in Carcinoid Syndrome
Roberts JL, Marney SR, Oates JA (1979) Blockage of the flush associated with metastatic gastric carcinoid by combined H1 and H2 receptor antagonists. Evidence for an important role of H2 receptors in human vasculature. N Engl J Med 300:236–238
Smith AG, Greaves MW (1974) Blood prostaglandin activity associated with noradrenaline-provoked flush in the carcinoid syndrome. Br J Dermatol 90:547–551
Familial Palmoplantar Erythema
Lane JE (1929) Erythema pamare hereditarium. Arch Dermatol Syphilol 20:445–448
Bryan HG, Coskey RJ (1967) Familial erythema of acral regions. Arch Dermatol 95:483–486
Figurate Erythemas
Hurley H, Hurley JP (1984) The gyrate erythemas. Semin Dermatol 3:327–336
Saurat JH, Janin-Mercier A (1984) Infantile epidermodys-plastic erythema gyratum responsive to imidazoles. A new entity? Arch Dermatol 1320:1601–1603
Summerly R (1964) The figurative erythemas and neoplasia. Br J Dermatol 76:370–373
Erythema Annulare Centrifugum
Bressler GS, Jones RE Jr (1981) Erythema annulare centrifugum. J Am Acad Dermatol 4:597–602
Darier J (1916) De l’érythème annulaire centrifuge (éry-thème papulocirciné migrateur et chronique) et de quelques éruptions analogues. Ann Dermatol Syph 7:57–76
Jilson D (1954) Allergic confirmation that some cases of erythema annulare centrifugum are dermatophytids. Arch Dermatol Syphilol 70:355–359
Mahboob A, Haroon TS (1998) Drugs causing fixed eruptions: a study of 450 cases. Int J Dermatol 37:833–838
Mahood JM (1983) Erythema annulare centrifugum. A review of 24 cases with special reference to its association with underlying disease. Clin Exp Dermatol 8:383–387
Reichel M, Wheeland RG (1991) Inflammatory carcinoma masquerading as erythema annulare centrifugum. Acta Derm Venereol (Stockh) 73:138–140
Shelley WB (1965) Erythema annulare centrifugum due to Candida albicans. Br J Dermatol 77:383–384
Trying SK (1993) Reactive erythemas: erythema annulare centrifugum and erythema gyratum repens. Clin Dermatol 11:135–139
Erythema Gyratum Repens
Albers SE, Fenske NA, Glass LF (1993) Erythema gyratum repens: direct immunofluorescence findings. J Am Acad Dermatol 29:493–494
Barber PV, Doyle L, Vickers KM, et al. (1978) Erythema gyratum repens with pulmonary tuberculosis. Br J Dermatol 98:465–468
Boyd AS, Neldner KH, Menter A (1992) Erythema gyratum repens: a paraneoplastic eruption. J Am Acad Dermatol 26:757–762
Gammel JA (1952) Erythema gyratum repens — skin manifestations in a patient with carcinoma of breast. Arch Dermatol Syphilol 66:494–505
Garret SJ, Roenigk HH Jr (1998) Erythema gyratum repens in a healthy woman. J Am Acad Dermatol 26:121–122
Kawakami T, Saito R (1995) Erythema gyratum repens un-associated with underlying malignancy. J Dermatol 22: 587–589
Kurzrock R, Cohen PR (1995) Erythema gyratum repens. JAMA 273:594
Annular Erythema of Infancy
Gianotti F, Ermacora E (1975) Erythema gyratum atrophicans transiens neonatale. Arch Dermatol 111:615–616
Erythema Gyratum Perstans
Beare JM, Frogatt P, Jones JH (1966) Familial annular erythema. An apparently new dominant mutation. Br J Dermatol 78:59–68
Friedman SJ, Winkelmann RK (1987) Familial granuloma annulare. Report of two cases and review of the literature. J Am Acad Dermatol 16:600–605
Erythema Marginatum
Burke JB (1993) Erythema marginatum. Arch Dis Child 30: 359–365
Gadrat J (1983) Sur les érythèmes rhumatismaux. Ann Dermatol Syph 9:1045–1051
Green ST,Harnlet NW, Willocks L (1990) Psittacosis presenting with erythema-marginatum-like lesions — a case report and a historical review. Clin Exp Dermatol 15: 225–227
Erythema Scarlatiniforme Desquamativum Recidivans
Lausecker H (1954) Das Erythema scarlatiniforme desquamativum recidivans. Arch Dermatol Syphilol 198: 529–548
Landthaler M, Michalopoulos M, Schwab U et al. (1985) Erythema scarlatiniforme desquamativum recidivans localisatum. Hautarzt 36:581–585
Necrolytic Migratory Erythema
Becker SW, Kahn D, Rothman S (1942) Cutaneous manifestations of internal malignant tumors. Arch Dermatol Syphilol 45:1069–1080
Burton JL (1993) Zinc and essential fatty acid therapy for necrolytic migratory erythema. Arch Dermatol 129:246
Doyle JA, Schroeter AL, Rogers RS III (1979) Hyperglucago-nemia and necrolytic migratory erythema in cirrhosis -possible pseudoglucagonoma syndrome. Br J Dermatol 101:581–587
Kheir SM, Omura EF, Grizzle WE et al. (1986) Histologic variation in the skin lesions of the glucagonoma syndrome. Am J Surg Pathol 10:445–453
Marinkovich MP, Botella R, Datloff J et al. (1995) Necrolytic migratory erythema without glucagonoma in patients with liver disease. J Am Acad Dermatol 32:604–609
Sheperd ME, Raimer SS, Tyring SK et al. (1991) Treatment of necrolytic migratory erythema in glucagonoma syndrome. J Am Acad Dermatol 25:925–928
Sinclair SA, Reynolds NJ (1997) Necrolytic migratory erythema and zinc deficiency. Br J Dermatol 136:783–785
Vandersteen PR, Scheithauer BW (1985) Glucagonoma syndrome. A clinicopathologic, immunocytochemical and ultrastructural study. J Am Acad Dermatol 12:1032–1039
Multiforme and Nodose Erythemas Erythema Multiforme
Aslanzadeh J, Helm KF, Espy JM et al. (1992) Detection of HSV-specific DNA in biopsy tissue of patients with erythema multiforme by polymerase chain reaction. Br J Dermatol 126:19–23
Aurelian L, Kokuba H, Burnett JW (1998) Understanding the pathogenesis of HSV-associated erythema multiforme. Dermatology 197:219–222
Bedi TR, Pinkus H (1976) Histopathological spectrum of erythema multiforme. Br J Dermatol 95:243–250
Choy AC, Yarnold PR, Brown JE et al. (1995) Virus induced erythema multiforme and Stevens-Johnson syndrome. Allergy Proc 16:157–161
Drago F, Parodi A, Rebora A (1995) Persistent erythema multiforme: report of two new cases and review of literature. J Am Acad Dermatol 33:366–369
Duvic M, Reisner EG, Dawson DV et al. (1983) HLA-B15 association with erythema multiforme. J Am Acad Dermatol 8:493–496
Fabbri P, Panconseni E (1993) Erythema multiforme (“minus” and “maius”) and drug intake. Clin Dermatol 11:479–489
Foedinger D, Anhalt GJ, Boecskoer B et al. (1995) Autoantibodies to desmoplakin I and II in patients with erythema multiforme. J Exp Med 181:169–179
Hewitt J, Ormerod AD (1992) Toxic epidermal necrolysis treated with cyclosporine. Clin Exp Dermatol 17:264–265
Huff JC (1988) Therapy and prevention of erythema multiforme with acyclovir. Semin Dermatol 7:212–217
Huff JC, Weston WL, Tonnesen MG (1983) Erythema multiforme: a critical review of characteristics, diagnostic criteria and causes. J Am Acad Dermatol 8:763–775
Lemak MA, Davis M, Bean SF (1986) Oral acyclovir for the prevention of herpes-associated erythema multiforme. J Am Acad Dermatol 15:50–54
Lewis DA, Brook MG (1992) Erythema multiforme as a presentation of human immunodeficiency virus seroconversion illness. Int J STD AIDS 3:56–57
Lyell A (1979) Toxic epidermal necrolysis (the scalded skin syndrome): a reappraisal. Br J Dermatol 100:69–86
Lyell A, Gordon AM, Dick HM (1967) Mycoplasmas and erythema multiforme. Lancet ii: 1116–1118
Miura S, Smith CC, Burnett JW et al. (1992) Detection of viral DNA within skin of healed recurrent herpes simplex infection and erythema multiforme lesions. J Invest Dermatol 98:68–72
Rzany B, Hering O, Mockenhaupt M et al. (1996) Histopatho-logical and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol 135:6–11
Shelley WB (1967) Herpes simplex virus as a cause of erythema multiforme. JAMA 201:153–156
Todd P, Halpern S, Munro DD (1995) Oral terbinafine and erythema multiforme. Clin Exp Dermatol 201 247–248
Wuepper KD, Watson PA, Katzmierowski JA (1980) Immune complexes in erythema multiforme and the Stevens-Johnson syndrome. J Invest Dermatol 74:368–371
Acute Febrile Neutrophilic Dermatosis
Cohen PR (1993) Pregnancy-associated Sweet’s syndrome: world literature review. Obstet Gynecol Surv 48:584–587
Cohen PR, Kurzrock R (1987) Sweet’s syndrome and malignancy. Am J Med 82:1220–1226
Cohen PR, Holder WR, Tucker SB et al. (1993) Sweet syndrome in patients with solid tumors. Cancer 72:2723–2731
Driesch P van den (1994) Sweet’s syndrome: acute febrile neutrophilic dermatosis. J Am Acad Dermatol 31:535–556
Hofmann C, Braun-Falco O, Petzoldt D (1976) Akute febrile neutrophile Dermatose (Sweet-Syndrom). Dtsch Med Wochenschr 101:1113–1118
Jeanfils S, Joly P, Young P (1997) Indomethacin treatment of eighteen patients with Sweet’s syndrome. J Am Acad Dermatol 36:436–439
Kemmett D, Hunter JAA, Berth-Jones J et al. (1989) Sweet’s syndrome and malignancy: a case associated with multiple myeloma and review of the literature. Br J Dermatol 121:123–128
Kemmett D, Hunter JAA, Berth-Jones J et al. (1989) Sweet’s syndrome: a clinicopathologic review of twenty nine cases. J Am Acad Dermatol 23:503–507
Storer JS, Nesbitt LT, Galen WK et al. (1983) Sweet’s syndrome: a review. Int J Dermatol 22:8–12
Sweet RD (1964) An acute febrile neutrophilic dermatosis. Br J Dermatol 76: 349–356
Sweet RD (1979) Acute febrile neutrophilic dermatosis -1978. Br J Dermatol 100:93–99
Tikjob G, Kassis V, Klem-Thomsen H et al. (1985) Acute febrile neutrophilic dermatosis and abnormal bone marrow chromosomes as a marker for preleukemia. Acta Derm Venereol (Stockh) 65:177–179
Walker DC, Cohen PR (1996) Trimethoprim-sulfamethoxa-zole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet’s syndrome. J Am Acad Dermatol 34:918–923
Pityriasis Rosea
Aiba S, Tagami H (1985) Immunohistologic studies in pityriasis rosea. Arch Dermatol 121:761–765
Aoshima T, Komura J, Ofiji S (1981) Virus-like particles in the herald patch of pityriasis rosea. Dermatologica 162: 64–65
Arndt KA, Paul BS, Stern RS et al. (1983) Treatment of pityriasis rosea with UV radiation. Arch Dermatol 119:381–382
Björnberg A, Hellgren L (1962) Pityriasis rosea: a statistical, clinical and laboratory investigation of 826 patients and matched healthy controls. Acta Derm Venereol (Stockh) 42 [Suppl 50]: 1–68
Drago F, Ranieri E, Malaguti F et al. (1997) Human herpesvirus 7 in pityriasis rosea. Lancet 349:1367–1368
Gibert GM (1860) Traité pratique des maladies de la peau et de la syphilis, 3rd edn. Plon, Paris, p 402
Leenutaphong V, Jiamtom S (1995) UVB phototherapy for pityriasis rosea. A bilateral comparison study. J Am Acad Dermatol 33:996–999
Marcus-Faber BS, Bergman R, Ben-Porath E et al. (1997) Serum antibodies to parvovirus B19 in patients with pityriasis rosea. Dermatology 194:371
Messenger AG, Knox EG, Summerly R et al. (1982) Case clustering in pityriasis rosea: support for role of an infective agent, Br Med J 284:371–373
Panizzon R, Bloch PH (1982) Histopathology of pityriasis rosea Gibert. Qualitative and quantitative lightmicro-scopic study of 62 biopsies of 40 patients. Dermatologica 165:551–558
Parsons JM (1986) Pityriasis rosea update:1986. J Am Acad Dermatol 15:159–167
Pierson JC, Dijkstra JW, Elston DM (1993) Purpuric pityriasis rosea. J Am Acad Dermatol 28:1021
Pityriasis Rotunda
Aste N, Pau M, Biggio P (1997) Pityriasis rotunda: a survey of 42 cases observed in Sardinia, Italy. Dermatology 194: 32–35
Grimait R, Gelmetti C, Brusasco A et al. (1994) Pityriasis rotunda: report of a familial occurrence and review of the literature. J Am Acad Dermatol 31:866–871
Psoriasis General
Abel EA, DiCicco LM, Orenberg EK et al. (1986) Drugs in exacerbation of psoriasis. J Am Acad Dermatol 15:1007–1022
Ashcroft DM, Li Wan A, Williams HC et al. (1999) Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their quality. Br J Dermatol 141: 185–191
Baker BS, Fry L (1992) The immunology of psoriasis. Br J Dermatol 126:1–9
Beutner EH (ed) (1984) Autoimmunity in psoriasis. CRC, Boca Raton
Bos JD (1988) The pathomechanism of psoriasis; the skin immune system and cyclosporine. Br J Dermatol 118: 141–155
Eedy DJ, Burrows D, Bridges JM et al. (1990) Clearance of severe psoriasis after allogenic bone marrow transplantation. BMJ 300:908
Gottlieb SL, Gilleaudeau P, Johnson R et al. (1995) Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nat Med 1:442–447
Kulick KB, Mogavero H Jr, Provost TT et al. (1983) Serologic studies in patients with lupus erythematosus and psoriasis. J Am Acad Dermatol 8:631–634
Menssen A, Trommler P, Vollmer S et al. (1995) Evidence for an antigen-specific cellular immune response in skin lesions of patients with psoriasis vulgaris. J Immunol 155:4078–4083
Naldi L, Peli L, Parazzini F (1999) Association of early-stage psoriasis with smoking and male alcohol consumption. Arch Dermatol 135:1479–1484
Obuch ML, Maurer TA, Becker B et al. (1992) Psoriasis and human immunodeficiency virus infection. J Am Acad Dermatol 27:667–673
Poikolainen K, Karvonen J, Pukkala E (1999) Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis. Arch Dermatol 135: 1490–1493
Prinz JC, Gross B, Vollmer S et al. (1994) T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro. Eur J Immunol 24:593–598
Roenigk HH, Maibach HI (eds) (1998) Psoriasis, 3rd edn. Dekker, New York
Valdimarson H, Baker BS, Jonsdottir I et al. (1986) Psoriasis: a disease of abnormal keratinocyte proliferation induced by T lymphocytes. Immunol Today 7:256–259
Valdimarsson H, Sigmundsdottir H, Jonsdottir I (1997) Is psoriasis induced by streptococcal superantigens and maintained by M-protein-specific T cells that cross-react with keratin? Clin Exp Immunol 107 [Suppl 1]: 21–24
Vollmer S, Menssen A, Trommler P et al. (1994) T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells. Eur J Immunol 24:2377–2382
Wrone Smith T, Nickoloff BJ (1996) Dermal injection of immunocytes induces psoriasis. J Clin Invest 98:1878–1887
Genetics
Christophers E, Henseler T (1992) Psoriasis type I and II as subtypes of nonpustular psoriasis. Semin Dermatol 11:261–266
Elder JT, Henseler T, Christophers E et al. (1994) Of genes and antigens: the inheritance of psoriasis. J Invest Dermatol 103:150S–153S
Farber EM, Nail ML, Watson W (1974) Natural history of psoriasis in 61 twin pairs. Arch Dermatol 109:207–210
Henseler T (1998) Genetics of psoriasis. Arch Dermatol Res 290:463–476
Henseler T, Christophers E (1985) Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 13:450–456
Jenisch S, Henseler T, Nair RP et al. (1998) Linkage analysis of human leukocyte antigen (HLA) markers in familial psoriasis: strong disequilibrium effects provide evidence for a major determinant in the HLA-B/-C region. Am J Hum Genet 63:191–199
Karvonen J (1975) HL-A antigens in psoriasis with special reference to the clinical type, age of onset, exacerbation after respiratory infections an occurrence of arthritis. Ann Clin Res 7:301–311
Karvonen J, Tiilikainen A, Lassus A (1975) HL-A antigen in patients with persistent palmoplantar pustulosis and pustular psoriasis. Ann Clin Res 7:112–115
Lerner MR, Lerner AB (1972) Congenital psoriasis. Arch Dermatol 105:598–602
Lomholt G (1963) Psoriasis: prevalence, spontaneous course and genetics. A census study on the prevalence of skin diseases on the Faroe Islands. G.E.C. GAD, Copenhagen
Matthews D, Fry L, Powles A et al. (1996) Evidence that a locus for familial psoriasis maps to chromosome 4q. Nat Genet 14:231–233
Nair RP, Guo SW, Jenisch S et al. (1995) Scanning chromosome 17 for psoriasis susceptibility: lack of evidence for a distal 17q locus. Hum Hered 45:219–230
Nair RP, Henseler T, Jenisch S et al. (1997) Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Hum Mol Genet 6:1349–1356
Russell TJ, Schultes LM, Kuban DJ (1972) Histocompatibility (HL-A) antigens associated with psoriasis. N Engl J Med 287:738–740
Tomfohrde J, Silverman A, Barnes R et al. (1994) Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome vq. Science 264:1141–1145
Trembath RC, Clough RL, Rosbotham JL et al. (1997) Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum Mol Genet 6:813–820
Clinical Features
Braun-Falco O (1963) Zur Morphogenese der psoriatischen Hautreaktion. Eine morphologisch-histochemische Studie. Arch Klin Exp Dermatol 216:130–154
Braun-Falco O, Christophers E (1974) Structural aspects of initial psoriatic lesions. Arch Dermatol Forsch 251:95–110
Braun-Falco O, Schmoeckel C (1977) The dermal inflammatory reaction in initial psoriatic lesions. Arch Dermatol Res 258:9–16
Christophers E, Parzefall R, Braun-Falco O (1973) Initial events in psoriasis: quantitative assessment. Br J Dermatol 89:327–334
Farber EM, Nall L (1992) Nail psoriasis. Cutis 50:174–178
Farber EM, Nall L (1992) Nonpustular palmoplantar psoriasis. Cutis 50:407–410
Farber EM, Nall L (1993) Psoriasis associated with human immunodeficiency virus/acquired immunodeficiency syndrome. Cutis 52:29–35
Lazar AP, Roenigk HH (1987) Aids and psoriasis. Cutis 39:347–351
Nickoloff BJ (1987) Interferons and psoriasis — 1987 perspective. Dermatologica 175:1–4
Ragaz A, Ackerman AB (1979) Evolution, maturation and regression of lesions of psoriasis. Am J Dermatopathol 1:199–214
Therapy
Abel EA, DiCicco LM, Orenberg EK et al. (1986) Drugs in exacerbation of psoriasis. J Am Acad Dermatol 15:1007–1022
Abels DJ, Kattan-Byron J (1985) Psoriasis treatment at the Dead Sea: a natural selective ultraviolet phototherapy. J Am Acad Dermatol 12:639–643
Altmeyer PJ, Matthes U, Pawlak F et al. (1994) Antipsoriatic effect of fumaric acid derivatives. Results of a multicen-ter double-blind study in 100 patients. J Am Acad Dermatol 30: 977–981
Berth-Jones J, Hutchinson PE (1992) Vitamin D analogues and psoriasis. Br J Dermatol 127:71–78
Berth Jones J, Voorhees JJ (1996) Consensus conference on cyclosporine microemulsion for psoriasis, June 1996. Br J Dermatol 135:775–777
Bos JD, Meinardi MM, Van Joost T et al. (1989) Use of cyclosporine in psoriasis. Lancet 2:1500–1502
Calzavara Pinton PG, Ortel B, Carlino et al. (1993) Photo-testing and phototoxic side effects in bath PUVA. J Am Acad Dermatol 28:657–659
Collins P, Rogers S (1992) The efficacy of methotrexate in psoriasis — a review of 40 cases. Clin Exp Dermatol 17: 257–260
Ellis CN, Voorhees JJ (1987) Etretinate therapy. J Am Acad Dermatol 16:267–291
Ellis CN, Gorsulowsky DC, Hamilton TA et al. (1986) Cyclosporine improves psoriasis in a double-blind study. JAMA 256:3110–3116
Ellis CN, Fradin MS, Hamilton TA et al. (1995) Duration of remission during maintenance cyclosporine therapy for psoriasis. Relationship to maintenance dose and degree of improvement during initial therapy. Arch Dermatol 131:791–795
Esgleyes Ribot T, Chandraratna RA, Lew Kaya DA et al. (1994) Response of psoriasis to a new topical retinoid, AGN190168. J Am Acad Dermatol 30:581–590
Farber EM, Nall L, Morhenn V et al. (1987) Psoriasis. Proceedings of the Fourth International Symposium. Elsevier, New York Amsterdam London
Farber EM (1992) History of the treatment of psoriasis. J Am Acad Dermatol 27:640–645
Farber EM, Harris DR (1970) Hospital treatment of psoriasis. A modified anthralin program. Arch Dermatol 101: 381–389
Gollnick H, Bauer R, Brindley C et al. (1988) Acitretin versus etretinate in psoriasis. Clinical and pharmacological results of a German multicenter study. J Am Acad Dermatol 19:458–469
Gollnick HP (1996) Oral retinoids — efficacy and toxicity in psoriasis. Br J Dermatol 135 [Suppl 49]: 6–17
Greaves MW, Weinstein GD (1995) Treatment of psoriasis. New Engl J Med 332:581–588
Heidbreder G, Christophers E (1979) Therapy of psoriasis with retinoid plus PUVA: clinical and histological data. Arch Dermatol 264:331–337
Henseler T, Christophers E, Hönigsmann H (1987) Skin tumors in the European PUVA Study. Eight year follow-up of 1643 patients treated with PUVA for psoriasis. J Am Acad Dermatol 16:108–116
Ingram JT (1954) The approach to psoriasis. Brit Med J ii: 591–594
Jekler J, Swanbeck G (1992) One-minute dithranol therapy in psoriasis: a placebo-controlled paired comparative study. Acta Dermato Venereol (Stockh) 72:449–450
Kerkhof PC van de (1998) An update on vitamin D3 analogues in the treatment of psoriasis. Skin Pharmacol Appl Skin Physiol 11:2–10
Kerscher M, Volkenandt M, Plewig G et al. (1993) Combination phototherapy of psoriasis with calcipotriol and narrow-band UVB. Lancet 342:923
Koo JY (1998) Tazarotene in combination with phototherapy. J Am Acad Dermatol 39: S144–S148
Koo J, Lebwohl M (1999) Duration of remission of psoriasis therapies. J Am Acad Dermatol 41:51–59
Kragballe K, Dam TN, Hansen ER et al. (1994) Efficacy and safety of the 20-epi-vitamin D3 analogue KH 1060 in the topical therapy of psoriasis: results of a dose-ranging study. Acta Derm Venereol 74:398–402
Lebwohl M, Ellis C, Gottlieb A et al. (1998) Cyclosporine consensus conference: with emphasis on the treatment of psoriasis. J Am Acad Dermatol 39:464–475
Lebwohl M, Poulin Y (1998) Tazarotene in combination with topical corticosteroids. J Am Acad Dermatol 39:8139
Lowe NJ, Wortzman MS, Breeding J et al. (1983) Coal tar phototherapy for psoriasis reevaluated: erythemogenic versus suberythemogenic ultraviolet with a tar extract in oil and crude coal tar. J Am Acad Dermatol 8:781–789
Marks JM (1986) Cyclosporin A treatment of severe psoriasis. Br J Dermatol 115:745–746
Menne T, Larsen K (1992) Psoriasis treatment with vitamin D derivatives. Semin Dermatol 11:278–183
Menter A, Cram DL (1983) The Goeckerman regimen in two psoriasis day care centers. J Am Acad Dermatol 9: 59–65
Michel G, Kemeny L, Homey B et al. (1996) FK506 in the treatment of inflammatory skin disease: promises and perspectives. Immunol Today 17:106–108
Morel P, Revillard JP, Nicolas JF et al. (1992) Anti-CD4 monoclonal antibody therapy in severe psoriasis. J Autoim-mun 5:465–477
Mrowietz U, Christophers E, Altmeyer P (1999) Treatment of severe psoriasis with fumaric acid esters: scientific background and guidelines for therapeutic use. Br J Dermatol 141:424–429
Ortel B, Perl S, Kinaciyan T et al. (1993) Comparison of narrow-band (311 nm) UVB and broad-band UVA after oral or bath-water 8-methoxypsoralen in the treatment of psoriasis. J Am Acad Dermatol 29:736–740
Peter RU, Ruzicka T (1992) Cyclosporin A in der Therapie entzündlicher Dermatosen. Hautarzt 43:687–694
Powles AV, Cook T, Huhne B et al. (1993) Renal function and biopsy findings after 5 years’ treatment with low-dose cyclosporine for psoriasis. Br J Dermatol 128:159–165
Powles AV, Hardman CM, Porter WM et al. (1998) Renal function after 10 years’ treatment with cyclosporine for psoriasis. Br J Dermatol 138:443–449
Prinz JC, Braun-Falco O, Meurer M et al. (1991) Chimeric CD4 monoclonal antibody in treatment of generalized pustular psoriasis. Lancet 338:320–321
Roenigk HH Jr, Auerbach R, Maibach H et al. (1998) Methotrexate in psoriasis: consensus conference. J Am Acad Dermatol 38:478–485
Runne U, Kunze JJ (1982) Short-duration (“minutes”) therapy with dithranol for psoriasis: a new out-patient regimen. Br J Dermatol 106:135–139
Shroot B (1986) Anthralin. Dermatologica 173:261–263
Speight EL, Farr PM (1994) Calcipotriol improves the response of psoriasis to PUVA. Br J Dermatol 130:79–82
Steigleder GK, Orfanos CE, Pullmann H (1979) Retinoid-SUP-Therapie der Psoriasis. Z Hautkr 54:19–23
Stern RS (1997) Psoriasis. Lancet 350:349–353
Stern RS, Nichols KT, Vakeva LH (1997) Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). N Engl J Med 336:1041–1045.
Stern RS, Lange R, Members of the Photochemotherapy Follow-up Study (1988) Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after treatment. J Invest Dermatol 91:120–124
Streit V, Wiedow O, Christophers E (1994) Innovative Balneotherapie mit reduzierten Badevolumina: Folienbäder. Hautarzt 45:140–144
Studniberg HM, Weller P (1993) PUVA, UVB, psoriasis, and nonmelanoma skin cancer. J Am Acad Dermatol 29:1013–1022
Tanew A, Ortel B, Rappersberger K et al. (1988) 5-methoxy-psoralen (Bergapten) for photochemotherapy. Bioavailability, phototoxicity, and clinical efficacy in psoriasis of a new drug preparation. J Am Acad Dermatol 18:333–338
Vallat VP, Gilleaudeau P, Battat L et al. (1994) PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: a possible cellular basis for remittive therapy. J Exp Med 180:283–296
Walters IB, Burack LH, Coven TR et al. (1999) Suberythemogenic narrow-band UVB is markedly more effective than conventional UVB in treatment of psoriasis vulgaris. J Am Acad Dermatol 40:893–900
Wang JTC, Krazmien RJ, Dahlheim CR (1986) Anthralin stain removal. J Am Acad Dermatol 15:951–955
Weinstein GD (1996) Safety, efficacy and duration of therapeutic effect of tazarotene used in the treatment of plaque psoriasis. Br J Dermatol 135 [Suppl 49]:32–36
Zachariae H, Abrams B, Bleehen SS et al. (1998) Conversion of psoriasis patients from the conventional formulation of cyclosporin to a new microemulsion formulation: a randomized, open, multicentre assessment of safety and tolerability. Dermatology 196:231–236
Zachariae H (2000) Liver biopsies and methotrexate: A time for recondsideration? J Am Acad Dermatol 42:531–534
Zaun H (1985) Orale Glukokortikosteroidtherapie bei Psoriasis vulgaris: Pro und Contra. Hautarzt 36:13–15
Pustular Psoriasis
Baker H, Ryan TJ (1968) Generalized pustular psoriasis. A clinical and epidemiological study of 104 cases. Br J Dermatol 8:771–793
Barber HW (1936) Pustular psoriasis of the extremities. Guy Hosp Rep 86:108
Braun-Falco O, Weidner F (1968) Psoriasis vom Typ des Erythema anulare centrifigum mit Pustulation. Hautarzt 19:109–115
Braun-Falco O, Berthold D, Ruzicka T (1987) Psoriasis pustulosa generalisata — Klassifikation, Klinik und Therapie. Übersicht und Erfahrungen an 18 Patienten. Hautarzt 38:509–520
Khan SA, Peterkin GA, Mitchell PC (1972) Juvenile generalized pustular psoriasis. A report of five cases and a review of the literature. Arch Dermatol 105: 167–72
Pearson LH, Allen BS, Smith JG Jr (1984) Acrodermatitis continua of Hallopeau: treatment with etretinate and review of relapsing pustular eruptions of the hands and feet. J Am Acad Dermatol 11:755–762
Peter RU, Ruzicka T, Donhauser G et al. (1990) Acrodermatitis continua-type of pustular psoriasis responds to low-dose cyclosporine. J Am Acad Dermatol 23: 515–516
Shelnitz LS, Esterly NB, Honig PJ (1987) Etretinate therapy for generalized pustular psoriasis in children. Arch Dermatol 123:230–233
Zelickson BD, Muller SA (1991) Generalized pustular psoriasis. A review of 63 cases. Arch Dermatol 127:1339–1345
Zumbusch LR von (1909–1910) Psoriasis und pustuloses Exanthem. Arch Dermatol Syph 99:335
Psoriatic Arthritis
Braun-Falco O, Ruzicka T (1994) Psoriatic arthritis. Int J Dermatol 33:320–322
Carette S, Calin A, McCafferty JP et al. (1989) A double-blind placebo-controlled study of auranofin in patients with psoriatic arthritis. Arthritis Rheum 32:158–165
Chamot AM, Benhamou CL, Kahn MF et al. (1987) Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey Rev Rheum Mal Osteoartic 54:187–196
Farr M, Kitas GD, Waterhouse L et al. (1988) Treatment of psoriatic arthritis with sulphasalazine: a one year open study. Clin Rheumatol 7:372–377
Feldges DH, Barnes CG (1974) Treatment of psoriatic arthropathy with either azathioprine or methotrexate. Rheumatol Rehabil 13:120–124
Gupta AK, Matteson EL, Ellis CN et al. (1989) Cyclosporine in the treatment of psoriatic arthritis. Arch Dermatol 125:507–510
Moll JMH (1986) Psoriatic arthropathy. In: Mier PD, Kerkhof PCM van de (eds) Textbook of psoriasis. Churchill Livingstone, Edinburgh, pp 55–83
Olsen TG (1981) Chloroquine and psoriasis. Ann Intern Med 94:546–549
Ruzicka T (1996) Psoriatic arthritis. New types, new treatments. Arch Dermatol 132:215–219
Salvarani C, Zizzi F, Macchioni P et al. (1989) Clinical response to auranofin in patients with psoriatic arthritis. Clin Rheumatol 8:54–57
Seideman P, Fjellner B, Johannesson A (1987) Psoriatic arthritis treated with oral colchicine. J Rheumatol 14: 777–779
Sonozaki H, Mitusi H, Miyanaga Y et al. (1981) Clinical features of 53 cases with pustulotic arthro-osteitis. Ann Rheum Dis 40:547–553
Watts RA, Crisp AJ, Hazleman BL et al. (1993) Arthroosteitis: a clinical spectrum. Br J Rheumatol 32:403–407
Reiter Syndrome
Aho K, Ahvonen P, Lassus A et al. (1974) HL-A 27 in reactive arthritis. A study of Yersinia arthritis and Reiter’s disease. Arthritis Rheum 17:521–526
Barron KS, Reveille JD, Carrington M et al. (1995) Susceptibility to Reiter’s syndrome is associated with alleles of TAP genes. Arthritis Rheum 38:684–689
Brewerton DA, Caffrey M, Nicholls A et al. (1973) Acute anterior uveitis and HL-A 27. Lancet 2:994–996
Butler MJ, Russell AS, Percy JS et al. (1979) A follow-up study of 48 patients with Reiter’s syndrome. Am J Med 67:808–810
Fiessinger N, Leroy E (1916) Contribution à l’étude d’une épidémie de dysenterie dans la Somme (juliett-octobre 1916) Bull Soc Med Hôp 40:2030–2069
Hughes RA, Keat AC (1994) Reiter’s syndrome and reactive arthritis: a current view. Semin Arthritis Rheum 24: 190–210
Marks JS, Holt PJ (1986) The natural history of Reiter’s disease — 21 years of observations. Q J Med 60:685–697
Reiter H (1916) Ueber eine bisher unbekannte Spirochaeten-infektion (Spirochaetosis arthitica). Dtsch Med Wochen-schr 42:1535–1536
WüTkens RF, Arnett FC, Bitter T et al. (1981) Reiter’s syndrome. Evaluation of preliminary criteria for definite disease. Arthritis Rheum 24:844–849
Yli Kerttula UI (1984) Clinical characteristics in male and female uro-arthritis or Reiter’s syndrome. Clin Rheumatol 3:351–360
Pityriasis Rubra Pilaris
Braun-Falco O, Ryckmanns F, Schmoeckel C et al. (1983) Pityriasis rubra pilaris: a clinico-pathological and therapeutic study with special reference to histochemistry, autoradiography, and electron microscopy. Arch Dermatol Res 275:287–295
Cohen PR, Prystowsky JH (1989) Pityriasis rubra pilaris: a review of diagnosis and treatment. J Am Acad Dermatol 20:801–807
Davidson CL, Winkelmann RK, Kierland RR (1969) Pityriasis rubra pilaris — follow up study of 57 patients. Arch Dermatol 100:175–183
Devergie A (1857) Pityriasis pilaris. In: Traité practique des maladies de la peau, 2nd edn. Martinet, Paris pp 454–464
Dicken CH (1994) Treatment of classic pityriasis rubra pilaris. J Am Acad Dermatol 31:997–999
Fleissner J, Happle R (1981) Etretinate in the treatment of juvenile pityriasis rubra pilaris. Arch Dermatol 117:749–750
Goldsmith LA, Weinrich AE, Shupack J (1982) Pityriasis rubra pilaris response to 13-cis-retinoic acid. J Am Acad Dermatol 6:1710–1715
Grimnalt R, Gelmetti C, Brusasco A et al. (1994) Pityriasis rotunda: report of a familial ocurrence and review of the literature. J Am Acad Dermatol 31:866–871
Martin AG, Weaver CC, Cockerell CJ et al. (1992) Pityriasis rubra pilaris in the setting of HIV infection: clinical behaviour and association with explosive cystic acne. Br J Dermatol 126:617–620
Meyer P, Voorst PC van (1989) Lack of effect of cyclosporine in pityriasis rubra pilaris. Acta Derm Venereol 69:272
Pavlidakey GP, Hashimoto K, Savoy LB et al. (1985) Stanazo-lol in the treatment of pityriasis rubra pilaris. Arch Dermatol 121:546–548
Piamphongsant T, Akaraphant R (1994) Pityriasis rubra pilaris: a new proposed classification. Clin Exp Dermatol 19:134–138
Soeprono FF (1986) Histologic criteria for the diagnosis of pityriasis rubra pilaris. Am J Dermatopathol 8:277–283
Vanderhooft SL, Francis JS, Holbrook KA et al. (1995) Familial pityriasis rubra pilaris. Arch Dermatol 131:448–453
Parapsoriasis
Altmann J (1984) Parapsoriasis: a histopathological review and classification. Semin Dermatol 3:14–21
Brocq L (1902) Les parapsoriasis. Ann Dermatol 3:433–468
Burg G, Dummer R (1995) Small plaque (digitate) parapsoriasis is an abortive cutaneous T cell lymphoma and is not mycosis fungoides. Arch Dermatol 131:336–338
Burg G, Hoffmann-Fezer G, Nikolowski J et al. (1981) Lym-phomatoid papulosis. Acta Derm Venereol (Stockh) 61:491–496
Cliff S, Cook MG, Ostlere LS et al. (1996) Segmental pityriasis lichenoides chronica. Clin Exp Dermatol 21:464–465
English JC, Collins M, Bryant-Bruce C (1995) Pityriasis lichenoides et varioliformis acuta and group-A beta hemolytic streptococcal infection. Int J Dermatol 34:642–644
Fink-Puches R, Soyer HP, Kerl H (1994) Febrile ulcerone-crotic pityriasis lichenoides et varioliformis acuta. J Am Acad Dermatol 30:261–263
Gelmetti C, Rigoni C, Alessi et al. (1990) Pityriasis lichenoides in children: a long term follow-up eighty-nine cases. J Am Acad Dermatol 23:473–478
Habermann R (1925) Über die akut verlaufende, nekroti-siernde Unterart der Pityriasis lichenoides (pityriasis lichenoides et varioliformis acuta). Dermatol Z 45:42–48
Hood AF, Mark EJ (1982) Histopathologic diagnosis of PLEVA and its clinical correlation. Arch Dermatol 118: 478–482
Hu CH, Winkelmann RK (1973) Digitate dermatosis. A new look at symmetrical small plaque parapsoriasis. Arch Dermatol 107:65–69
Jacobi E (1906) Fall zur Diagnose. (Poikiloderma vascularis atrophicans). Verh Deut Dermatol Ges, 9th Congress, pp 321–323
Jadassohn J (1894) Über ein eigenartiges psoriasiformes und lichenoides Exanthem. In: Verhandlung Deut Dermatol Ges, 4th Congress Breslau, p 524
Juliusberg F (1899) Über die Pityriasis lichenoides chronica (psoriasiform-lichenoides Exanthem). Arch Dermatol Syph 50:359–374
Kikuchi A, Naka W, Harada T et al. (1993) Parapsoriasis en plaques: its potential for progression to malignant lymphoma. J Am Acad Dermatol 29:419–422
Lambert WB, Everett MA (1981) The nosology of parapsoriasis. J Am Acad Dermatol 5:373–395
Le Vine MJ (1983) Phototherapy for pityriasis lichenoides. Arch Dermatol 119:378–380
Longley J, Demar L, Feinstein RP et al. (1987) Clinical and histological features of pityriasis lichenoides et varioliformis acuta in children. Arch Dermatol 123:1335–1339
Maekawa Y, Nakamura T, Nogami R (1994) Febrile ulcero-necrotic Mucha-Habermann’s disease. J Dermatol 21: 46–49
Mucha V (1916) Über einen der Parakeratosis variegate (Unna) bzw. Pityriasis lichenoides chronica (Neisser-Juliusberg) nahestehenden eigentümlichen Fall. Arch Dermatol Syphilol 123:586–592
Muhlbauer JE, Bhan AK (1984) Immunopathology of PLEVA. J Am Acad Dermatol 10:783–795
Panizzon RG, Speich R, Dazzi H (1992) Atypical manifestations of pityriasis lichenoides chronica: development into paraneoplasia and non-Hodgkin lymphomas of the skin. Dermatology 184:65–69
Radcliffe-Crocker H (1905) Xanthoerythroderma perstans. Br J Dermatol 17:119–134
Rogers M (1992) Pityriasis lichenoides and lymphomatoid papulosis. Semin Dermatol 11:73–79
Rongioletti F, Rivara G, Rebora A (1987) Pityriasis lichenoides et varioliformis acuta and acquired toxoplasmosis. Dermatologica 175:41–44
Ross S, Sanchez JL (1990) Parapsoriasis. A century later. Int J Dermatol 29:329–330
Suarez J, Lopez B, Vilalba R et al. (1996) Febrile ulcerone-crotic Mucha-Habermann disease: a case report and review of the literature. Dermatology 192:277–279
Takahashi K, Atsumi M (1993) Pityriasis lichenoides chronica resolving after tonsillectomy. Br J Dermatol 129: 353–354
Truhan AP, Hebert AA, Esterly NB (1986) Pityriasis lichenoides in children: therapeutic response to erythromycin. J Am Acad Dermatol 15:66–70
Unna PG, Santi DR, Pollitzer S (1890) Über die Parakeratosen im Allgemeinen und eine neue Form derselben (Parakeratosis variegata). Monatsch Prakt Dermatol 10:404–412, 444–459
Vella Briffa D, Warin AP, Calnon CD (1979) Parakeratosis variegata: a report of two cases and their treatment with PUVA. Clin Exp Dermatol 4:537–541
Papuloerythroderma
Depaire F, Dereure O, Guilhou J (1996) Ofuji’s papuloerythroderma: report of a new case responding to PUVA. Acta Derm Venereol (Stockh) 76:93–94
Dwyer CM, Chapman RS, Smith GD (1994) Papuloerythroderma and cutaneous T cell lymphoma. Dermatology 188:326–328
Garcia-Patos V, Repiso T, Rodriguez-Cano L et al. (1996) Ofuji papuloerythroderma in a patient with the acquired immunodeficiency syndrome. Dermatology 192:164–166
Harris DW, Spencer MJ, Tidman MJ (1990) Papuloerythroderma — clinical and ultrastructural features. Clin Exp Dermatol 15:105–106
Ofuji S, Furukawa F, Miyachi Y et al. (1984) Dermatologica 169:125–130
Tay YK, Tan KC, Wong WK et al. (1994) Papuloerythroderma of Ofuji: a report of three cases and review of the literature. Br J Dermatol 130:773–776
Erythroderma
Abel EA, Lindae ML, Hoppe TR et al. (1988) Benign and malignant forms of cutaneous erythroderma: cutaneous immunophenotypic characteristics. J Am Acad Dermatol 19:1089–1095
Boyd AS, Menter A (1989) Erythrodermic psoriasis. J Am Acad Dermatol 21:985–991
Hasan T, Jansen CT (1983) Erythroderma. A follow-up of fifty cases. J Am Acad Dermatol 8:836–840
Krook G (1960) Hypothermia in patients with exfoliative dermatitis. Acta Derm Venereol 40:142–160
Montgomery H (1933) Exfoliative dermatosis and malignant erythroderma: the value and limitations of histopathologic studies. Arch Dermat Syphil 27:253
Nicolis GD, Hewig EB (1973) Exfoliative dermatitis. A clini-copathologic study of 135 cases. Arch Dermatol 108: 788–797
Pal S, Haroon TS (1998) Erythroderma: a clinico-etiologic study of 90 cases. Int J Dermatol 37:104–107
Rubins AY, Hartmane IV, Lielbriedis YM et al. (1992) Therapeutic options for erythroderma. Cutis 49:424–426
Sentis HJ, Willemze R, Scheffer E (1986) Histopathologic studies of Sézary syndrome and erythrodermic mycosis fungoides: a comparison with benign forms of erythroderma. J Am Acad Dermatol 15:1217–1226
Shuster S, Wilkinson P (1963) Protein metabolism in exfoliative dermatitis and erythroderma. Br J Dermatol 75: 344–353
Sigurdsson V, Toonstra J, Vloten WA van (1997) Idiopathic erythroderma: a follow-up study of 28 patients. Dermatology 194: 198–101
Thestrup-Pedersen K, Halkier-S0rensen L, S0gaard H et al. (1988) The red man syndrome. J Am Acad Dermatol 18:1307–1312
Walsh NM, Prokopetz R, Tron VA et al. (1994) Histopatholo-gy in erythroderma: review of a series of cases by multiple observers. J Cutan Pathol 21:419–423
Winkelmann RK, Buechner SA, Diaz-Perez JL (1984) Pre-Sézary syndrome. J Am Acad Dermatol 10:992–999
Worm AM, Taaning E, Rossing N (1981) Distribution and degradation of albumin in extensive skin disease. Br J Dermatol 104:389–396
Lichen Planus
Acactingi S, Chosidow O (1998) Cutaneous graft-versus-host disease. Arch Dermatol 134:602–612
Annessi G, Signoretti S, Angelo C et al. (1997) Neutrophilic figurate erythema of infancy. Am J Dermatopathol 19: 403–406
Bellman B, Reddy RK, Falanga V (1995) Lichen planus associated with hepatitis C. Lancet 346:1234
Black MM (1977) What is going on in lichen planus. Clin Exp Dermatol 2:303–310
Camisa C, Hamaty FG, Gay JD (1998) Squamous cell carcinoma of the tongue arising in lichen planus: a case report and review of the literature. Cutis 62:175–178
Cram DL, Kierland RR, Winkelmann RK (1966) Ulcerative lichen planus of the feet. Arch Dermatol 93:692–701
Cribier B, Frances C, Chosidow O (1998) Treatment of lichen planus. An evidence-based medicine analysis of efficacy. Arch Dermatol 134:1521–1530
Crotty CP, Su WPD, Winkelmann RK (1980) Ulcerative lichen planus. Follow-up of surgical excision and grafting. Arch Dermatol 116:1252–1256
Ellgehausen P, Eisner P, Burg G (1998) Drug-induced lichen planus. Clin Dermatol 16: 325–332
Fellner MJ (1980) Lichen planus. Int J Dermatol 19:71–75
Hintner H, Tappeiner G, Hönigsmann H et al. (1979) Lichen planus and bullous pemphigoid. Acta Dermato Venereol (Stockh) 59 [Suppl 85]: 71–76
Katzenellenbogen I (1962) Lichen planus actinicus (lichen planus in subtropical countries). Dermatologica 124:10–20
Kronenberg K, Fretzing D, Potter B (1971) Malignant degeneration of lichen planus. Arch Dermatol 104:304–307
Oliver GF, Winkelmann RK (1993) Treatment of lichen planus. Drugs 45:56–65
Plotnick H, Burnham TK (1986) Lichen planus and coexisting lupus erythematosus versus lichen planus-like lupus erythematosus. Clinical, histologic, and immunopatho-logic considerations. J Am Acad Dermatol 14:931–938
Powell FC, Rogers RS, Dickson ER et al. (1986) An association between HLA DR1 and lichen planus. Int J Dermatol 114:473–478
Ragaz A, Ackerman B (1981) Evolution, maturation and regression of lesions of lichen planus. New observations and correlation of clinical and histologic findings. Am J Dermatopathol 3:5–25
Sehgal VN, Abraham GIS, Malik GB (1972) Griseofulvin therapy in lichen planus: a double-blind controlled trial. Brit J Dermatol 87:383–385
Shklar P (1968) Erosive and bullous oral lesions of lichen planus. Arch Dermatol 97:411–416
Tosti A, Peluso AM, Fanti PA et al. (1993) Nail lichen planus: clinical and pathologic study of twenty-four patients. J Am Acad Dermatol 28:724–730
Wilson E (1869) On leichen planus. J Cutan Med Dis Skin 3:117–132
Woo TY (1985) Systemic isotretinoin treatment of oral and cutaneous lichen planus. Cutis 35:385–393
Lichen Nitidus
Chen W, Schramm M, Zouboulis CC (1997) Generalized lichen nitidus. J Am Acad Dermatol 36:630–631
Mihara M, Nakayama H, Shimao S (1991) Lichen nitidus: a histologic and electron microscopic study. J Dermatol 18:475–480
Pinkus F (1907) Über eine neue knochenformige Hauteruption: Lichen nitidus. Arch Dermatol Syph 85:11–36
Smoller BR, Flynn TC (1992) Immunohistochemical examination of liehen nitidus suggests that it is not a localized papular variant of lichen planus. J Am Acad Dermatol 27:232–236
Actinic Lichen Nitidus
Bedi TR (1978) Summertime actinic lichenoid eruption. Dermatológica 157:115–125
Hussain K (1998) Summertime actinic lichenoid eruption, a distinct entity, should be termed actinic lichen nitidus. Arch Dermatol 134:1302–1303
Graft Versus Host Disease
Aractingi S, Chosidow O (1998) Cutaneous graft-versus-host disease. Arch Dermatol 134:602–612
Atkinson K, Horowitz MM, Biggs JC (1988) The clinical diagnosis of acute graft-versus-host disease: a diversity of views amongst marrow transplant centers. Bone Marrow Transplant 3:5–10
Chosidow O, Bagot M, Vernant JP et al. (1992) Sclerodermatous chronic graft-versus-host disease. Analysis of seven cases. J Am Acad Dermatol 26:49–55
Darmstadt GL, Donnenberg AD, Vogelsang GB (1992) Clinical, laboratory, and histopathologic indications of the development of progressive acute graft-versus-host disease. J Invest Dermatol 99:397–402
Ferrara JL, Deeg HJ (1991) Graft-versus-host disease. N Engl J Med 324:667–664
Gale RP, Horowitz MM, Butturini A et al. (1992) What determines who develops graft-versus-host disease: the graft or the host (or both)? Bone Marrow Transplant 10:99–102
Greinix HAT, Volc-Platzer B, Rabitsch W et al. (1998) Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. Blood 92:3098–3104
Kelemen E, Szebeni J, Petranyi GG (1993) Graft-versus-host disease in bone marrow transplantation: experimental, laboratory, and clinical contributions of the last few years. Int Arch Allergy Immunol 102:309–320
Loughran TP Jr, Sullivan K, Morton T et al. (1990) Value of day 100 screening studies for predicting the development of chronic graft-versus-host disease after allogeneic bone marrow transplantation. Blood 76:228–234
Rowe JM, Ciobanu N, Ascensao J et al. (1994) Recommended guidelines for the management of autologous and allogeneic bone marrow transplantation. A report from the Eastern Cooperative Oncology Group (ECOG). Ann Intern Med 120:143–158
Saurat JH (1981) Cutaneous manifestations of graft-versus-host disease. Int J Dermatol 20:249–256
Saurat JH, Gluckman E, Bussel A et al. (1975) The lichen planus-like eruption after bone marrow transplantation. Br J Dermatol 93:675–681
Schiller G, Gale RP (1993) Is there an effective therapy for chronic graft-versus-host disease? Bone Marrow Transplant 11:189–192
Siadak MF, Kopecky K, Sullivan KM (1994) Reduction in transplant-related complications in patients given intravenous immuno globulin after allogeneic marrow transplantation. Clin Exp Immunol 97 [Suppl 1]: 53–57
Tanaka K, Sullivan KM, Shulman HM (1991) A clinical review: cutaneous manifestations of acute and chronic graft-versus-host disease following bone marrow transplantation. J Dermatol 18:11–17
Volc-Platzer B, Hönigsmann H, Hinterberger W (1990) Photochemotherapy improves chronic cutaneous graft-versus-host disease. J Am Acad Dermatol 23:220–228
Frictional Lichenoid Dermatitis
Asthon RE, Russel-Jones R, Griffiths WAD (1985) Juvenile plantar dermatosis. Arch Dermatol 121:253–260
Jones SK, English JSC, Forsyth A (1987) Juvenile plantar dermatosis — an 8-year follow-up of 102 patients. Clin Exp Dermatol 1:5–7
McKie RM (1982) Juvenile plantar dermatosis. Semin Dermatol 1:67–71
McKie RM, Husain SL (1976) Juvenile plantar dermatosis. A new entity? Clin Exp Dermatol 1:253–260
Moller H (1972) Atopic winter feet in children. Acta Dermato Venereol (Stockh) 52:401–405
Sutton RL, Jr (1956) Diseases of the skin, 11th edn. Mosby, St. Louis, p 898
Waisman M, Sutton RL (1966) Frictional lichenoid eruption in children. Arch Dermatol 94:592–593
Gianotti-Crosti Syndrome
Baldari U, Monti A, Righini MG (1994) An epidemic of infantile papular acrodermatitis (Gianotti-Crosti syndrome) due to Epstein-Barr virus. Dermatology 188: 203–204
Braun-Falco O, Rupee M (1964) Über das Gianotti-Crosti-Syndrom (Acrodermatitis papulosa eruptiva infantilis). Med Klin 52:210–214
Caputo R, Gelmetti C, Ermacora E (1992) Gianotti-Crosti syndrome: a retrospective analysis of 308 cases. J Am Acad Dermatol 26:207–210
Carrascosa JM, Just M, Ribera M (1998) Papular acrodermatitis of childhood related to poxvirus and parvovirus B19 infection. Cutis 61:265–267
Crosti A, Gianotti F (1956) Dermatosi infantile eruttiva acroesposta di probabile orgine virosica. Minerva Dermatol 31 (Suppl 12): 483
Crosti A, Gianotti F (1964) Ulteriore contributo alla conos-cenza delPacrodermatite papulosa infantile. G Ital Derm 105:477
Gianotti F (1955) Rilievi di una particolare casisistica tos-sinfettiva caratterizzata da eruzione eritemato-infiltra-tiva desquamativa a focolai lenticolari, a sede elettiva acroesposta. G Ital Derm Sif 96:678–697
Gianotti F (1973) Papular acrodermatitis of childhood. Arch Dis Child 43:794–799
Gianotti F (1979) Papular acrodermatitis of childhood and other papulovesicular acro-located syndromes. Br J Dermatol 100: 49–59
James WD, Odom RB, Hatch MH (1982) Gianotti-Crosti-like eruption associated with Coxsackie A-16 infection. J Am Acad Dermatol 6:862–866
Lowe L, Hebert AA, Duvic M (1989) Gianotti-Crosti syndrome associated with Epstein-Barr virus infection. J Am Acad Dermatol 20:336–338
Ramelet A-A (1984) Mononucléose infectieuse avec manifestations cutanées à type d’acrosyndrome de Gianotti-Crosti. Dermatologica 168:19–24
Sagi EF, Linden N, Shonval D (1985) Papular acrodermatitis of childhood associated with hepatitis A virus infection. Pediatr Dermatol 3:31–33
Spear KL, Winkelmann RK (1984) Gianotti-Crosti syndrome. Arch Dermatol 120:891–896
Taieb A, Plantin P, du Pasquier P et al. (1986) Gianotti-Crosti syndrome: a study of 26 cases. Br J Dermatol 115:49–59
Lichen Simplex Chronicus
Berlin C (1939) Lichenification gigantea (Lichenification géante of Brocq and Pautrier). Arch Dermatol 39:1012–1020
Brocq, Pautrier (1910) Über einige abnormale Formen von Lichenifikation. Arch Dermatol Syph 99:421
Kantor GR, Resnik KS (1996) Treatment of lichen simplex chronicus with topical capsaicin cream. Acta Derm Venereol 76:161
Kinsella LJ, Carney-Godley K, Feldmann E (1992) Lichen simplex chronicus as the initial manifestation of intramedullary neoplasm and syringomyelia. Neurosurgery 30:418–421
Robertson IM, Jordan JM, Withlock FA (1975) Emotions and skin (III) — the conditioning of scratch responses in cases of lichen simplex. Br J Dermatol 92:407–412
Singh G (1973) Atopy in lichen simplex (neurodermatitis circumscripta). Br J Dermatol 88:625–627
Vidal E (1886) Du lichen (lichen, prurigo, strophulus) Ann Derm Syph 7:133–154
Lichen Striatus
Gianotti R, Restano L, Grimait R (1995) Lichen striatus — a chameleon: an histopathological and immunohistologi-cal study of forty-one cases. J Cutan Pathol 22:18–22
Grosshans E, Margot L (1990) Blaschkite de Fadulte. Ann Dermatol Venereol 117:9–15
Herd RM, McLaren KM, Aldrige RD (1993) Linear lichen planus and lichen striatus — opposite ends of a spectrum. Clin Exp Dermatol 19:335–337
Karp DL, Cohen BA (1993) Onychodystrophy in lichen striatus. Pediatr Dermatol 10:359–361
Kaufman J (1974) Lichen striatus with nail involvement. Cutis 14:232–234
Taieb A, El-Youbi A, Grosshans E et al. (1991) Lichen striatus: a Blaschko linear acquired inflammatory skin eruption. J Am Acad Dermatol 25:637–642
Toda K, Okamoto H, Horio T (1986) Lichen striatus. Int J Dermatol 25:584–585
Tosti A, Peluso AM, Misciali C (1997) Nail lichen striatus: clinical features and long-term follow-up of five patients. J Am Acad Dermatol 36:908–913
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Braun-Falco, O., Plewig, G., Wolff, H.H., Burgdorf, W.H.C. (2000). Erythemato-Papulo-Squamous Diseases. In: Dermatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-97931-6_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-97931-6_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-97933-0
Online ISBN: 978-3-642-97931-6
eBook Packages: Springer Book Archive